Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading BioCryst Pharma. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni BioCryst Pharma.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli BioCryst Pharmaceuticals Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per BioCryst Pharmaceuticals Inc
Numero di azioni emesse
209.920M
Azioni possedute dagli insider
7.327M
Percentuale posseduta dagli Insider
3.49%
Azioni possedute dagli investitori istituzionali
102.097M
Percentuale posseduta dagli investitori istituzionali
48.6%
Aug 15, 2025 | DIRECTOR | 0.00 | $6.43 | -$292.17K | SELL-OPTIONS | 0.00% | 65.35K | Aug 13 | ||
Dec 16, 2024 | DIRECTOR | -7.00K | $7.54 | -$52.78K | SELL | -7.48% | 86.64K | Dec 13 | ||
Jun 25, 2024 | DIRECTOR | -8.60K | $6.32 | -$54.35K | SELL | -23.61% | 27.83K | Jun 24 | ||
Jun 17, 2024 | DIRECTOR | -4.69K | $6.00 | -$28.13K | SELL | -14.46% | 27.74K | Jun 17 | ||
Jun 14, 2024 | DIRECTOR | 122.00 | $6.11 | -$40.92K | GRANT | 0.23% | 52.85K | Jun 12 - Jun 14 | ||
May 31, 2024 | DIRECTOR | 7.86K | $6.36 | $50.00K | BUY | 21.19% | 44.95K | May 30 | ||
May 29, 2024 | DIRECTOR | 2.50K | $6.40 | $16.00K | BUY | 3.95% | 65.84K | May 24 | ||
May 22, 2024 | DIRECTOR | 5.00K | $6.38 | $31.90K | BUY | 6.11% | 86.82K | May 20 | ||
May 22, 2024 | DIRECTOR | 15.00K | $6.25 | $93.75K | BUY | 28.85% | 67.00K | May 20 | ||
May 15, 2024 | CHIEF FINANCIAL OFFICER | 36.30K | $5.57 | $202.19K | BUY | 15.75% | 266.74K | May 14 | ||
May 15, 2024 | CHIEF R&D OFFICER | 30.00K | $5.86 | $175.80K | BUY | 12.39% | 272.14K | May 14 | ||
May 15, 2024 | DIRECTOR | 21.94K | $5.49 | $120.45K | BUY | 74.09% | 51.55K | May 13 | ||
May 15, 2024 | CHIEF LEGAL OFFICER | 5.00K | $5.53 | $27.65K | BUY | 1.69% | 300.76K | May 13 | ||
May 15, 2024 | PRESIDENT & CEO | 30.00K | $5.55 | $166.50K | BUY | 2.68% | 1.15M | May 13 | ||
May 15, 2024 | CHIEF COMMERCIAL OFFICER | 30.00K | $5.47 | $164.10K | BUY | 10.81% | 307.53K | May 13 | ||
Jun 15, 2023 | DIRECTOR | 12.74K | $7.98 | -$31.92K | GRANT | 99.06% | 25.61K | Jun 13 - Jun 15 | ||
Jun 15, 2023 | DIRECTOR | 3.88K | $8.04 | -$103.44K | GRANT | 4.98% | 81.82K | Jun 13 - Jun 14 | ||
Apr 05, 2023 | CHIEF R&D OFFICER | -7.00K | $8.29 | -$58.03K | SELL | -3.27% | 207.28K | Apr 03 | ||
Feb 02, 2023 | PRESIDENT & CEO | 0.00 | $7.92 | -$493.00K | SELL-OPTIONS | 0.00% | 1.01M | Dec 29 - Feb 01 | ||
Dec 19, 2022 | PRESIDENT & CEO | -14.10K | $10.90 | -$153.69K | SELL | -1.55% | 892.73K | Dec 15 | ||
Dec 19, 2022 | CHIEF R&D OFFICER | -3.13K | $10.89 | -$34.03K | SELL | -2.29% | 133.28K | Dec 15 | ||
Dec 19, 2022 | CHIEF FINANCIAL OFFICER | -5.70K | $10.90 | -$62.13K | SELL | -3.36% | 163.97K | Dec 15 | ||
Dec 19, 2022 | CHIEF COMMERCIAL OFFICER | -6.10K | $10.90 | -$66.49K | SELL | -2.80% | 211.61K | Dec 15 | ||
Dec 19, 2022 | EXEC. DIRECTOR, FINANCE - PAO | -445.00 | $10.90 | -$4.85K | SELL | -3.97% | 10.75K | Dec 15 | ||
Dec 19, 2022 | CHIEF LEGAL OFFICER | -4.17K | $10.88 | -$45.42K | SELL | -2.06% | 198.77K | Dec 15 | ||
Dec 02, 2022 | EXEC. DIRECTOR, FINANCE - PAO | 0.00 | $7.21 | -$99.67K | SELL-OPTIONS | 0.00% | 11.20K | Dec 01 | ||
Dec 02, 2022 | PRESIDENT & CEO | 0.00 | $7.18 | -$3.43M | SELL-OPTIONS | 0.00% | 906.83K | Dec 01 - Dec 02 | ||
Nov 16, 2022 | CHIEF DISCOVERY OFFICER | 68.48K | $7.65 | -$295.43K | SELL-OPTIONS | 29.77% | 298.54K | Nov 14 | ||
Apr 20, 2022 | DIRECTOR | 0.00 | $7.18 | -$38.60K | SELL-OPTIONS | 0.00% | 0.00 | Apr 18 | ||
Apr 04, 2022 | CHIEF R&D OFFICER | -7.60K | $16.20 | -$123.12K | SELL | -5.28% | 136.40K | Apr 01 | ||
Mar 14, 2022 | CHIEF MEDICAL OFFICER | -12.84K | $10.05 | -$2.24M | SELL | -25.27% | 37.95K | Mar 10 | ||
Mar 09, 2022 | CHIEF DISCOVERY OFFICER | -20.00K | $17.16 | -$343.20K | SELL | -8.00% | 230.06K | Mar 07 | ||
Mar 03, 2022 | EXEC. DIRECTOR, FINANCE - PAO | 0.00 | $10.96 | -$28.68K | SELL-OPTIONS | 0.00% | 11.20K | Mar 01 | ||
Feb 16, 2022 | DIRECTOR | 0.00 | $10.91 | -$75.90K | SELL-OPTIONS | 0.00% | 0.00 | Feb 15 | ||
Jan 13, 2022 | PRESIDENT & CEO | 0.00 | $9.88 | -$1.90M | SELL-OPTIONS | 0.00% | 906.60K | Jan 11 | ||
Dec 09, 2021 | CHIEF DISCOVERY OFFICER | 31.90K | $8.46 | -$73.96K | SELL-OPTIONS | 17.42% | 215.06K | Dec 07 | ||
Nov 24, 2021 | DIRECTOR | 7.50K | $12.19 | $91.42K | BUY | 75.00% | 17.50K | Nov 24 | ||
Nov 24, 2021 | CHIEF FINANCIAL OFFICER | 35.26K | $12.48 | $440.02K | BUY | 60.31% | 93.72K | Nov 23 | ||
Nov 17, 2021 | DIRECTOR | 0.00 | $7.79 | -$44.75K | SELL-OPTIONS | 0.00% | 0.00 | Nov 15 | ||
Oct 19, 2021 | DIRECTOR | 0.00 | $9.43 | -$1.25M | SELL-OPTIONS | 0.00% | 65.07K | Oct 15 | ||
Sep 17, 2021 | DIRECTOR | 0.00 | $8.85 | -$62.15K | SELL-OPTIONS | 0.00% | 0.00 | Sep 15 | ||
Sep 15, 2021 | DIRECTOR | 9.00K | $9.29 | -$43.80K | SELL-OPTIONS | 59.01% | 24.25K | Sep 13 | ||
Sep 14, 2021 | DIRECTOR | -3.00K | $8.97 | -$913.95K | SELL | -100.00% | 0.00 | Sep 10 | ||
Jul 19, 2021 | DIRECTOR | 0.00 | $9.16 | -$65.30K | SELL-OPTIONS | 0.00% | 3.00K | Jul 15 | ||
Jun 14, 2021 | DIRECTOR | 0.00 | $10.01 | -$319.85K | SELL-OPTIONS | 0.00% | 65.07K | Jun 10 | ||
Jun 01, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $10.17 | -$1.58M | SELL-OPTIONS | 0.00% | 14.47K | May 27 - May 28 | ||
May 26, 2021 | DIRECTOR | 0.00 | $8.27 | -$75.14K | SELL-OPTIONS | 0.00% | 3.00K | May 24 | ||
May 13, 2021 | CHIEF LEGAL OFFICER | 35.85K | $8.17 | -$642.45K | SELL-OPTIONS | 32.51% | 146.13K | May 11 - May 12 | ||
May 12, 2021 | DIRECTOR | -7.00K | $12.70 | -$88.90K | SELL | -70.00% | 3.00K | May 10 | ||
Feb 24, 2021 | SENIOR VP - CMO | 0.00 | $7.86 | -$306.07K | SELL-OPTIONS | 0.00% | 11.47K | Feb 22 | ||
Dec 17, 2020 | — | 0.00 | $6.24 | -$559.94K | OPTION EXERCISE | 0.00% | 784.09K | Dec 15 | ||
Dec 15, 2020 | — | 0.00 | $6.05 | -$52.35K | OPTION EXERCISE | 0.00% | 108.06K | Dec 11 | ||
Dec 08, 2020 | — | 0.00 | $5.19 | -$28.58K | OPTION EXERCISE | 0.00% | 108.06K | Dec 04 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.